Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 250

204.60p
   
  • Change Today:
      0.40p
  • 52 Week High: 220.40
  • 52 Week Low: 140.45
  • Currency: UK Pounds
  • Shares Issued: 2,000.51m
  • Volume: 4,676,579
  • Market Cap: £4,093.03m
  • RiskGrade: 194

CTEC Overview

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.
Competitors: Akers Biosciences, Inc., Consort Medical, Advanced Medical Solutions

Key Personnel

Chairman: John McAdam
CEO: Karim Bitar
CFO: Frank Schulkes
Independent Non-Executive Director: Regina Benjamin
Senior Independent Non-Executive Director: Margaret Ewing
Non-Executive Dir: Ros Rivaz , Brian May, Sten Scheibye, Rick Anderson

Contact Details

Address: 3, Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH
Website: http://www.convatecgroup.com

Listings

Sector: Health Care(LSE)
Index: FTSE 250FTSE 350FTSE All-Share
ISIN: GB00BD3VFW73

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 204.60p
Change Today 0.40p
% Change 0.20 %
52 Week High 220.40
52 Week Low 140.45
Volume 4,676,579
Shares Issued 2,000.51m
Market Cap £4,093.03m
RiskGrade 194

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.49% below the market average47.49% below the market average47.49% below the market average47.49% below the market average47.49% below the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average
Price Trend
67.20% above the market average67.20% above the market average67.20% above the market average67.20% above the market average67.20% above the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average
Income
42.62% below the market average42.62% below the market average42.62% below the market average42.62% below the market average42.62% below the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Growth
94.18% below the market average94.18% below the market average94.18% below the market average94.18% below the market average94.18% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 4
Sell 1
Strong Sell 2
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Final Interim
Ex-Div 02-Apr-20 05-Sep-19
Paid 14-May-20 17-Oct-19
Amount 3.98¢ 1.72¢

Trades for 05-Jun-2020

Time Volume / Share Price
16:35 2,416,268 @ 204.60p
16:29 43 @ 203.00p
16:29 132 @ 203.00p
16:29 1,108 @ 203.00p
16:29 298 @ 203.00p

CTEC Key Personnel

CFO Frank Schulkes
CEO Karim Bitar
Chair John McAdam

Top of Page